1. EMA: Zabdeno (Ad26.ZEBOV-GP, recombinant) an overview of Zabdeno and why it is authorised in the EU. 2020. EMA/298997/2020.
2. EMA: Jcovden1 (COVID-19 vaccine (Ad26.COV2-S [recombinant])) an overview of Jcovden and why it is authorised in the EU. 2022. EMA/203645/2022.
3. EMA: Vaxzevria1 (COVID-19 Vaccine (ChAdOx1-S [recombinant])). an overview of Vaxzevria and why it is authorised in the EU. 2022. EMA/110683/2022.
4. Structural organization and protein-protein interactions in human adenovirus capsid;Reddy;Subcell Biochem,2021
5. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture;Rowe;Proc Soc Exp Biol Med,1953